巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Caladrius Biosciences

    CLBS
    0.471
    0.010
    1.49%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Caladrius Biosciences - 延遲價格・最後更新於 27/05 12:14
    最高位
    0.471
    最低位
    0.470
    開市價
    --
    前收市價
    0.478
    成交量(千)
    1.10
    成交額(百萬)
    0.00
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    28.49
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    1.680 - 0.402
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Caladrius Biosciences
    證券代碼
    CLBS.US
    所屬板塊
    Biotechnology
    公司業務
    Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its current product candidates include XOWNA, HONEDRA and CLBS201.
    發行量
    60533064
    公司總部
    110 Allen Road, 2nd Floor
    公司網址
    http://www.caladrius.com
    公司電郵
    jmenditto@caladrius.com
    公司電話
    +1 908 842-0100
    暫無內容

    關於

    Caladrius Biosciences(CLBS.US)所屬的行業板塊為Biotechnology。
    Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its current product candidates include XOWNA, HONEDRA and CLBS201.
    詳細公司背景可參考: http://www.caladrius.com